|
|
Article: Haemacure Corporation Announces CDN$12.5 Million Private Placement.
- Article from:
- PR Newswire Europe
- Article date:
- December 11, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MONTREAL, Quebec, December 11 /PRNewswire/ -- Haemacure Corporation (HAE: TSX) announced today that it is in the process of effecting a private placement in a maximum amount of CDN$12.5 million, the proceeds of which will be used primarily to finance the development of the fibrin sealant Hemaseel(TM)HMN, Haemacure's Phase III product, and the haemostatic agent Hemaseel(TM)Thrombin. Firebird Global Master Fund, Ltd. and Firebird Global Master Fund II, Ltd., both affiliated with New York-based Firebird Management LLC, have confirmed that they will be lead investors in the placement, for an aggregate amount of CDN$2.5 million. The private placement has also received ...